Skip to main content

Table 2 Patient characteristics

From: Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma

No. of patients

33

Male/Female

25/8

Age, years: median (range)

66 (55--82)

Performance status (ECOG)

 

0/1/2

6/21/6

Stage (UICC 1997)

 

I*

6

IIA/B

3/3

III

15

IVA/B

3/3

TNM clinical classification (UICC 1997)

 

T1/T2/T3/T4

7/3/12/11

N0/N1

10/23

M0/M1 lym

27/6

Pathology

 

Well/Mod/Poor

4/25/4

Location

 

Upper/Middle/Lower

3/19/11

  1. ECOG, Eastern Cooperative Oncology Group; UICC, International Union Against Cancer; M1 lym, M1 lymph node metastasis; Well, well-differentiated squamous carcinoma; Mod, moderately-differentiated squamous carcinoma; Poor, poorly-differentiated squamous carcinoma
  2. *: disease with submucosal invasion